⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)

Official Title: Role of Geriatric Intervention in Treatment of Older Patients With Cancer : a Phase III Randomized Study (PREPARE)

Study ID: NCT02704832

Study Description

Brief Summary: Randomized trials have already demonstrated that geriatric intervention was able to improve survival in the general elderly population but only a few have been performed in cancer patients. At the end, these data are not sufficient to consider geriatric intervention as validated in this setting. Case Management, coordinated by a geriatrician and a trained nurse, could improve prognosis of elderly patients with cancer. This approach, can be integrated in daily oncology practice. This strategy will be compared to usual oncological management in a randomized phase III trial.

Detailed Description: Patients will first be screened using the G8 screening tool. If the resulting score is altered (G8 \<= 14), patients will be included in the main study and randomized according to 2 modalities: Arm A / Usual care (treatment according to on-going regimens in oncology) or Arm B /Case management (assessment of the patient by the nurse and the geriatrician with interventions as prescribed by the geriatrician). The intervention will be considered effective if, at one year, compared to usual care there is a significant clinical improvement in overall survival (OS) without a significant deterioration or/and clinical improvement of at least one of the targeted quality of life (QoL) scores, without significant clinical deterioration in at least one of the targeted QoL scores and without significant difference in OS in favor of usual care. If the resulting score is normal (G8 \> 14), patients will be treated according to their physician-in-charge opinion. A minimal set of data will be collected (age, sex, tumor type, disease stage, performance status (PS), creatinine clearance, albumin and C-Reactive Protein (CRP) levels mainly) to allow for the characterization of the population in order to compare our results to those of other published series.

Eligibility

Minimum Age: 70 Years

Eligible Ages: OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Centre Hospitalier Universitaire de Grenoble, Grenoble, Rhône Alpes, France

Institut de Cancérologie de l'Ouest, Angers, , France

Centre Hospitalier de Beauvais, Beauvais, , France

Institut Bergonié Centre Régional de Lutte Contre le Cancer, Bordeaux, , France

CHU de Bordeaux, Bordeaux, , France

Clinique Anne d'Artois, Béthune, , France

Centre Hospitalier Universitaire de Caen, Caen, , France

Infirmerie Protestante de Lyon, Caluire-et-Cuire, , France

Centre Hospitalier Intercommunal de Castres Mazamet, Castres, , France

Centre Hospitalier Métropôle Savoie Chambéry, Chambéry, , France

Centre Hospitalier de Chinon, Chinon, , France

Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, , France

Centre Jean Perrin, Clermont-Ferrand, , France

AP-HP Henri Mondor, Créteil, , France

Centre Hospitalier Intercommunal de Créteil, Créteil, , France

Centre Hospitalier de Dax, Dax, , France

Centre Georges François Leclerc, Dijon, , France

Centre Hospitalier Universitaire de Martinique, Fort De France, , France

Centre Hospitalier Emile Roux, Le Puy-en-Velay, , France

Centre Hospitalier Universitaire de Lille, Lille, , France

Clinique Mutualiste Eugène André, Lyon, , France

Hôpital Saint Joseph Saint Luc, Lyon, , France

Centre Léon Bérard, Lyon, , France

Institut Paoli Calmettes, Marseille, , France

Centre Hospitalier de Mont de Marsan, Mont de Marsan, , France

Institut de Cancérologie de Montpellier, Montpellier, , France

Institut de Cancérologie de Lorraine, Nancy, , France

Centre Catherine de Sienne, Nantes, , France

Centre Hospitalier Universitaire de Nîmes, Nîmes, , France

AP-HP Hôpital Saint Louis, Paris, , France

Centre Hospitalier de Pau, Pau, , France

Hospices Civils de Lyon, Pierre Bénite, , France

Centre CARIO - HPCA, Pleurin Sur Mer, , France

Centre Hospitalier Universitaire de Poitiers, Poitiers, , France

Centre Hospitalier René Dubos, Pontoise, , France

Centre Hospitalier Annecy Genevois, Pringy, , France

Polyclinique Francheville, Périgueux, , France

Centre Hospitalier Intercommunal de Cornouaille, Quimper, , France

Centre Jean Godinot, Reims, , France

Centre Hospitalier Universitaire de Rennes, Rennes, , France

Centre Eugène Marquis, Rennes, , France

Centre Hospitalier Universitaire de Rouen, Rouen, , France

Centre Hospitalier Privé de Saint Grégoire, Saint Grégoire, , France

Centre Hospitalier Universitaire de Nantes, Saint Herblain, , France

Centre Hospitalier de Saint-Malo, Saint-Malo, , France

GHPSO Senlis Creil Picardie, Senlis, , France

Centre Hospitalier Universitaire de Strasbourg, Strasbourg, , France

Institut Claudius Regaud, Toulouse, , France

Centre Hospitalier de Tourcoing, Tourcoing, , France

Centre Hospitalier Universitaire de Tours, Tours, , France

Contact Details

Name: Pierre-Louis SOUBEYRAN, PU-PH

Affiliation: Institut Bergonié

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: